Skip to main navigation Skip to search Skip to main content

Pituitary incidentaloma: a Pituitary Society international consensus guideline statement

  • & The Pituitary Society International Incidentaloma Consensus Group
  • Oregon Health ad Science University
  • Cambridge University Hospitals NHS Foundation Trust
  • University of New South Wales
  • Kobe University Hospital
  • Universidade de São Paulo
  • Centre Hospitalier Universitaire de Sherbrooke
  • Tel Aviv University
  • The Nathan Kline Institute for Psychiatric Research and New York University Langone Medical Center, Orangeburg, United States
  • Rabin Medical Center Israel
  • Mayo Clinic
  • Carol Davila University of Medicine and Pharmacy
  • Aix Marseille University
  • Division of Endocrinology, Department of Medicine, University of Virginia, School of Medicine, Charlottesville, Virginia; and.
  • University of Basel
  • Institute of Post Graduate Medical Education and Research Kolkatta
  • University of Nebraska Medical Center
  • Vagelos College of Physicians and Surgeons, Columbia University
  • Universidade Federal do Rio de Janeiro
  • Vita-Salute San Raffaele University
  • Hospital Clínic, Barcelona, Spain
  • North Estonia Medical Center
  • Hospital Militar Central
  • Cedars-Sinai Medical Center
  • University College London Hospitals
  • Marmara University
  • Northwestern University Feinberg School of Medicine
  • Harvard Medical School
  • LMU University Hospital Grosshadern
  • Universidad de la República
  • University of Rochester Medical Center
  • Hospital Pablo Tobon Uribe
  • Nara Medical University
  • Medical University of Vienna
  • University of Southern California
  • University of Birmingham

Research output: Contribution to journalReview articleAcademicpeer-review

44 Downloads (Pure)

Abstract

This Pituitary Society Consensus article presents an evidence-based consensus on the management of pituitary incidentaloma, defined as an unexpected sellar or parasellar finding incidentally discovered on an imaging study that was not performed for a clinically suspected pituitary lesion. Recommendations are offered for when endocrinology, neurosurgery and ophthalmology consultation, dedicated pituitary imaging, pituitary hormone testing and visual assessment are warranted for macroadenomas, microadenomas, cystic lesions and empty sella, as well as when surgical resection is indicated for incidental pituitary adenomas and cystic sellar lesions. Special considerations in patients with multiple endocrine neoplasia type 1, children and adolescents, older people, and pregnant women are addressed. The Consensus workshop concluded that diagnostic and management approaches should be individualized to the specific clinical context of an incidentally discovered pituitary lesion. Consultation with a multidisciplinary pituitary tumour centre of excellence should be considered in the presence of new or deteriorating lesion-specific signs or symptoms, particularly when surgical or other adjuvant interventions are being considered and when there is uncertainty about the most appropriate subsequent management.

Original languageEnglish
Pages (from-to)638-655
Number of pages18
JournalNature reviews. Endocrinology
Volume21
Issue number10
Early online date24 Jun 2025
DOIs
Publication statusPublished - Oct 2025

Fingerprint

Dive into the research topics of 'Pituitary incidentaloma: a Pituitary Society international consensus guideline statement'. Together they form a unique fingerprint.

Cite this